p27Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803
- Citation:
- Clin Cancer Res vol 15 2116-2122
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, CA33601, U10 CA071323, CA77597, U10 CA077658, CA47577, CA32291, CA29165, U10 CA045564, U10 CA035279, U10 CA045808, U10 CA031946, U10 CA033601, U10 CA077597, U10 CA035421, U10 CA114558, U10 CA045418, U10 CA077440, U10 CA037447, U10 CA041287, U10 CA037447-27, U10 CA047559, U10 CA077651, CA04326, CA71323, CA45418, U10 CA074811, U10 CA047642, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Monica M. Bertagnolli Robert S. Warren Donna Niedzwiecki Elke Mueller Carolyn C. Compton Mark Redston Margaret Hall Hejin P. Hahn Scott D. Jewell Robert J. Mayer Richard M. Goldberg Leonard B. Saltz Massimo Loda
- Networks:
- Study
- CALGB-150705
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-89803
- Phases:
- N/A, 3
- Keywords:
- Colorectal cancer, adjuvant therapy, biomarkers